3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
OTHER
1
NIH
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Small Cell Lung Carcinoma
1
Lung Neoplasms
1
Carcinoma, Non-Small-Cell Lung
1
Interventions
Cyclophosphamide
178
Radiotherapy
147
Paclitaxel
128
Carboplatin
124
Bevacizumab
123
Cisplatin
119
Doxorubicin
111
Fluorouracil
107
Etoposide
102
Filgrastim
99
Vincristine
88
Leucovorin
82
Bortezomib
80
Gemcitabine
76
aldesleukin
74
Sorafenib
70
Cytarabine
70
Taxes
69
fludarabine phosphate
67
Irinotecan
66
Docetaxel
64
Oxaliplatin
60
sargramostim
58
Sirolimus
58
temsirolimus
56
Erlotinib Hydrochloride
56
Methotrexate
55
Rituximab
54
Vorinostat
52
Radiation
51
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
NIH
×
Tomography, Spiral Computed
×
Clear all
NCT00047385
2014-05-20
NLST
National Cancer Institute (NCI)
Phase 3
Completed
53,454 enrolled
15 charts